Proposed Use of Continuous Glucose Monitoring for Care of Critically Ill COVID-19 Patients | Zendy

Ivana Jankovic | Zendy; Marina Basina | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Proposed Use of Continuous Glucose Monitoring for Care of Critically Ill COVID-19 Patients

Author(s) -

Ivana Jankovic,

Marina Basina

Publication year - 2020

Publication title -

journal of diabetes science and technology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.039

H-Index - 75

eISSN - 1932-3107

pISSN - 1932-2968

DOI - 10.1177/1932296820965203

Subject(s) - glycemic , medicine , covid-19 , critically ill , intensive care medicine , continuous glucose monitoring , diabetes mellitus , insulin , blood glucose self monitoring , hypoglycemia , disease , infectious disease (medical specialty) , virology , endocrinology , outbreak

Coronavirus disease 2019 (COVID-19) has disproportionately affected patients with diabetes. Mounting evidence has shown that adequate inpatient glycemic control may decrease the risk of mortality. In critically ill patients, insulin drips are the most effective means of controlling blood glucose. However, resource limitations such as the availability of protective equipment and nursing time have discouraged the use of insulin drips during COVID-19. In this commentary, we review existing evidence on the importance of glycemic control in COVID-19 patients with diabetes and propose a protocol for utilizing continuous glucose monitors (CGMs) to improve glycemic control by decreasing the need for bedside management in critically ill COVID-19 patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research